BI 10773(Empagliflozin)2 型糖尿病患者的心血管结果事件试验(EMPA-REG 结果)。
2016年4月7日 更新者:Boehringer Ingelheim
BI 10773(10 毫克和 25 毫克,每天口服一次)与心血管风险增加的 2 型糖尿病患者的常规治疗相比,一项 III 期、多中心、国际、随机、平行组、双盲心血管安全性研究
本研究的目的是调查 BI 10773 治疗 2 型糖尿病和高心血管风险患者的安全性。
研究概览
研究类型
介入性
注册 (实际的)
7064
阶段
- 第三阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Frederiksberg、丹麦
- 1245.25.45006 Boehringer Ingelheim Investigational Site
-
Gentofte、丹麦
- 1245.25.45003 Boehringer Ingelheim Investigational Site
-
Helsingør、丹麦
- 1245.25.45007 Boehringer Ingelheim Investigational Site
-
København NV、丹麦
- 1245.25.45002 Boehringer Ingelheim Investigational Site
-
Randers NØ、丹麦
- 1245.25.45004 Boehringer Ingelheim Investigational Site
-
Slagelse、丹麦
- 1245.25.45005 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Kharkiv、乌克兰
- 1245.25.75009 Boehringer Ingelheim Investigational Site
-
Kharkiv、乌克兰
- 1245.25.75011 Boehringer Ingelheim Investigational Site
-
Kharkov、乌克兰
- 1245.25.75001 Boehringer Ingelheim Investigational Site
-
Kharkov、乌克兰
- 1245.25.75008 Boehringer Ingelheim Investigational Site
-
Kiev、乌克兰
- 1245.25.75007 Boehringer Ingelheim Investigational Site
-
Kiev、乌克兰
- 1245.25.75012 Boehringer Ingelheim Investigational Site
-
Odessa、乌克兰
- 1245.25.75010 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Batumi、乔治亚州
- 1245.25.99001 Boehringer Ingelheim Investigational Site
-
Kutaisi、乔治亚州
- 1245.25.99003 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99002 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99004 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99005 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99006 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99007 Boehringer Ingelheim Investigational Site
-
Tbilisi、乔治亚州
- 1245.25.99008 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Afula、以色列
- 1245.25.97003 Boehringer Ingelheim Investigational Site
-
Hadera、以色列
- 1245.25.97006 Boehringer Ingelheim Investigational Site
-
Haifa、以色列
- 1245.25.97008 Boehringer Ingelheim Investigational Site
-
Holon、以色列
- 1245.25.97009 Boehringer Ingelheim Investigational Site
-
Nahariya、以色列
- 1245.25.97005 Boehringer Ingelheim Investigational Site
-
Safed、以色列
- 1245.25.97001 Boehringer Ingelheim Investigational Site
-
Zerifin、以色列
- 1245.25.97002 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Barnaul、俄罗斯联邦
- 1245.25.70019 Boehringer Ingelheim Investigational Site
-
Kemerovo、俄罗斯联邦
- 1245.25.70015 Boehringer Ingelheim Investigational Site
-
Kemerovo、俄罗斯联邦
- 1245.25.70020 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70003 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70009 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70011 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70016 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70021 Boehringer Ingelheim Investigational Site
-
Moscow、俄罗斯联邦
- 1245.25.70022 Boehringer Ingelheim Investigational Site
-
Novosibirsk、俄罗斯联邦
- 1245.25.70014 Boehringer Ingelheim Investigational Site
-
Novosibirsk、俄罗斯联邦
- 1245.25.70018 Boehringer Ingelheim Investigational Site
-
Novosibirsk、俄罗斯联邦
- 1245.25.70024 Boehringer Ingelheim Investigational Site
-
Novosibirsk、俄罗斯联邦
- 1245.25.70028 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、俄罗斯联邦
- 1245.25.70005 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、俄罗斯联邦
- 1245.25.70025 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、俄罗斯联邦
- 1245.25.70026 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、俄罗斯联邦
- 1245.25.70027 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70001 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70004 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70006 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70013 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70017 Boehringer Ingelheim Investigational Site
-
St. Petersburg、俄罗斯联邦
- 1245.25.70023 Boehringer Ingelheim Investigational Site
-
Vsevolozhsk、俄罗斯联邦
- 1245.25.70002 Boehringer Ingelheim Investigational Site
-
Yaroslavl、俄罗斯联邦
- 1245.25.70029 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Karlovac、克罗地亚
- 1245.25.71005 Boehringer Ingelheim Investigational Site
-
Krapinske Toplice、克罗地亚
- 1245.25.71001 Boehringer Ingelheim Investigational Site
-
Osijek、克罗地亚
- 1245.25.71006 Boehringer Ingelheim Investigational Site
-
Rijeka、克罗地亚
- 1245.25.71003 Boehringer Ingelheim Investigational Site
-
Zagreb、克罗地亚
- 1245.25.71002 Boehringer Ingelheim Investigational Site
-
Zagreb、克罗地亚
- 1245.25.71004 Boehringer Ingelheim Investigational Site
-
-
-
-
British Columbia
-
Vancouver、British Columbia、加拿大
- 1245.25.20047 Boehringer Ingelheim Investigational Site
-
-
Manitoba
-
Winnipeg、Manitoba、加拿大
- 1245.25.20048 Boehringer Ingelheim Investigational Site
-
-
Nova Scotia
-
Halifax、Nova Scotia、加拿大
- 1245.25.20026 Boehringer Ingelheim Investigational Site
-
-
Ontario
-
Brampton、Ontario、加拿大
- 1245.25.20045 Boehringer Ingelheim Investigational Site
-
Burlington、Ontario、加拿大
- 1245.25.20042 Boehringer Ingelheim Investigational Site
-
Newmarket、Ontario、加拿大
- 1245.25.20009 Boehringer Ingelheim Investigational Site
-
Niagara Falls、Ontario、加拿大
- 1245.25.20044 Boehringer Ingelheim Investigational Site
-
Ottawa、Ontario、加拿大
- 1245.25.20013 Boehringer Ingelheim Investigational Site
-
Toronto、Ontario、加拿大
- 1245.25.20049 Boehringer Ingelheim Investigational Site
-
-
Quebec
-
Gatineau、Quebec、加拿大
- 1245.25.20050 Boehringer Ingelheim Investigational Site
-
Longueuil、Quebec、加拿大
- 1245.25.20043 Boehringer Ingelheim Investigational Site
-
Longueuil、Quebec、加拿大
- 1245.25.20046 Boehringer Ingelheim Investigational Site
-
-
Saskatchewan
-
Saskatoon、Saskatchewan、加拿大
- 1245.25.20041 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Budapest、匈牙利
- 1245.25.36002 Boehringer Ingelheim Investigational Site
-
Budapest、匈牙利
- 1245.25.36004 Boehringer Ingelheim Investigational Site
-
Budapest、匈牙利
- 1245.25.36008 Boehringer Ingelheim Investigational Site
-
Dunaujvaros、匈牙利
- 1245.25.36006 Boehringer Ingelheim Investigational Site
-
Gyula、匈牙利
- 1245.25.36001 Boehringer Ingelheim Investigational Site
-
Kisvarda、匈牙利
- 1245.25.36010 Boehringer Ingelheim Investigational Site
-
Szekszard、匈牙利
- 1245.25.36003 Boehringer Ingelheim Investigational Site
-
Szikszo、匈牙利
- 1245.25.36011 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Alberton、南非
- 1245.25.76007 Boehringer Ingelheim Investigational Site
-
Bellville、南非
- 1245.25.76002 Boehringer Ingelheim Investigational Site
-
Bloemfontein、南非
- 1245.25.76009 Boehringer Ingelheim Investigational Site
-
Cape Town、南非
- 1245.25.76014 Boehringer Ingelheim Investigational Site
-
Cape Town、南非
- 1245.25.76020 Boehringer Ingelheim Investigational Site
-
Chatsworth Unit 10、南非
- 1245.25.76022 Boehringer Ingelheim Investigational Site
-
Durban、南非
- 1245.25.76013 Boehringer Ingelheim Investigational Site
-
Durban、南非
- 1245.25.76016 Boehringer Ingelheim Investigational Site
-
Durban、南非
- 1245.25.76019 Boehringer Ingelheim Investigational Site
-
Goodwood、南非
- 1245.25.76003 Boehringer Ingelheim Investigational Site
-
Houghton、南非
- 1245.25.76001 Boehringer Ingelheim Investigational Site
-
Kempton Park、南非
- 1245.25.76021 Boehringer Ingelheim Investigational Site
-
Krugersdorp、南非
- 1245.25.76017 Boehringer Ingelheim Investigational Site
-
Newtown、南非
- 1245.25.76004 Boehringer Ingelheim Investigational Site
-
Paarl、南非
- 1245.25.76006 Boehringer Ingelheim Investigational Site
-
Parow、南非
- 1245.25.76005 Boehringer Ingelheim Investigational Site
-
Port Elizabeth、南非
- 1245.25.76018 Boehringer Ingelheim Investigational Site
-
Somerset West、南非
- 1245.25.76015 Boehringer Ingelheim Investigational Site
-
Sydenham、南非
- 1245.25.76012 Boehringer Ingelheim Investigational Site
-
Tongaat、南非
- 1245.25.76008 Boehringer Ingelheim Investigational Site
-
Worcester、南非
- 1245.25.76023 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Ahmedabad、印度
- 1245.25.91307 Boehringer Ingelheim Investigational Site
-
Bangalore、印度
- 1245.25.91302 Boehringer Ingelheim Investigational Site
-
Bangalore、印度
- 1245.25.91317 Boehringer Ingelheim Investigational Site
-
Bangalore、印度
- 1245.25.91319 Boehringer Ingelheim Investigational Site
-
Bangalore、印度
- 1245.25.91320 Boehringer Ingelheim Investigational Site
-
Chennai、印度
- 1245.25.91303 Boehringer Ingelheim Investigational Site
-
Cochin、印度
- 1245.25.91315 Boehringer Ingelheim Investigational Site
-
Hyderabad、印度
- 1245.25.91311 Boehringer Ingelheim Investigational Site
-
Indore、印度
- 1245.25.91318 Boehringer Ingelheim Investigational Site
-
Jaipur、印度
- 1245.25.91305 Boehringer Ingelheim Investigational Site
-
Jalandhar、印度
- 1245.25.91309 Boehringer Ingelheim Investigational Site
-
Nagpur、印度
- 1245.25.91313 Boehringer Ingelheim Investigational Site
-
Nagpur、印度
- 1245.25.91324 Boehringer Ingelheim Investigational Site
-
Nashik, Maharashtra、印度
- 1245.25.91301 Boehringer Ingelheim Investigational Site
-
Pune、印度
- 1245.25.91308 Boehringer Ingelheim Investigational Site
-
Secunderabad、印度
- 1245.25.91316 Boehringer Ingelheim Investigational Site
-
Varanasi、印度
- 1245.25.91321 Boehringer Ingelheim Investigational Site
-
Vijaywada、印度
- 1245.25.91314 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Denpasar, Bali、印度尼西亚
- 1245.25.62006 Boehringer Ingelheim Investigational Site
-
Depok、印度尼西亚
- 1245.25.62009 Boehringer Ingelheim Investigational Site
-
Jakarta、印度尼西亚
- 1245.25.62002 Boehringer Ingelheim Investigational Site
-
Jakarta、印度尼西亚
- 1245.25.62008 Boehringer Ingelheim Investigational Site
-
Jakarta、印度尼西亚
- 1245.25.62010 Boehringer Ingelheim Investigational Site
-
Malang、印度尼西亚
- 1245.25.62004 Boehringer Ingelheim Investigational Site
-
Surabaya、印度尼西亚
- 1245.25.62003 Boehringer Ingelheim Investigational Site
-
Yogyakarta、印度尼西亚
- 1245.25.62001 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Hualien、台湾
- 1245.25.88022 Boehringer Ingelheim Investigational Site
-
Kaohsiung、台湾
- 1245.25.88010 Boehringer Ingelheim Investigational Site
-
Kaohsiung、台湾
- 1245.25.88019 Boehringer Ingelheim Investigational Site
-
Taichung、台湾
- 1245.25.88009 Boehringer Ingelheim Investigational Site
-
Taichung、台湾
- 1245.25.88020 Boehringer Ingelheim Investigational Site
-
Tainan、台湾
- 1245.25.88018 Boehringer Ingelheim Investigational Site
-
Taipei、台湾
- 1245.25.88015 Boehringer Ingelheim Investigational Site
-
Taipei、台湾
- 1245.25.88016 Boehringer Ingelheim Investigational Site
-
Tamsui, Taipei county、台湾
- 1245.25.88023 Boehringer Ingelheim Investigational Site
-
Taoyuan、台湾
- 1245.25.88017 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Armenia、哥伦比亚
- 1245.25.57010 Boehringer Ingelheim Investigational Site
-
Barranquilla、哥伦比亚
- 1245.25.57004 Boehringer Ingelheim Investigational Site
-
Bogotá、哥伦比亚
- 1245.25.57001 Boehringer Ingelheim Investigational Site
-
Bogotá、哥伦比亚
- 1245.25.57003 Boehringer Ingelheim Investigational Site
-
Bogotá、哥伦比亚
- 1245.25.57011 Boehringer Ingelheim Investigational Site
-
Floridablanca、哥伦比亚
- 1245.25.57006 Boehringer Ingelheim Investigational Site
-
Medellín、哥伦比亚
- 1245.25.57009 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Colonia Americana、墨西哥
- 1245.25.52009 Boehringer Ingelheim Investigational Site
-
Distrito Federal、墨西哥
- 1245.25.52007 Boehringer Ingelheim Investigational Site
-
Ladron de Guevara、墨西哥
- 1245.25.52013 Boehringer Ingelheim Investigational Site
-
Los Robles、墨西哥
- 1245.25.52010 Boehringer Ingelheim Investigational Site
-
Monterrey、墨西哥
- 1245.25.52001 Boehringer Ingelheim Investigational Site
-
Reforma Social、墨西哥
- 1245.25.52011 Boehringer Ingelheim Investigational Site
-
San Lucas tepetlcalco、墨西哥
- 1245.25.52012 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Busan、大韩民国
- 1245.25.82030 Boehringer Ingelheim Investigational Site
-
Daegu、大韩民国
- 1245.25.82018 Boehringer Ingelheim Investigational Site
-
Daejeon、大韩民国
- 1245.25.82021 Boehringer Ingelheim Investigational Site
-
Daejoen、大韩民国
- 1245.25.82031 Boehringer Ingelheim Investigational Site
-
Goyang、大韩民国
- 1245.25.82027 Boehringer Ingelheim Investigational Site
-
Gwangju、大韩民国
- 1245.25.82022 Boehringer Ingelheim Investigational Site
-
Incheon、大韩民国
- 1245.25.82029 Boehringer Ingelheim Investigational Site
-
Pusan、大韩民国
- 1245.25.82017 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82015 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82016 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82019 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82020 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82023 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82024 Boehringer Ingelheim Investigational Site
-
Seoul、大韩民国
- 1245.25.82025 Boehringer Ingelheim Investigational Site
-
Suwon、大韩民国
- 1245.25.82026 Boehringer Ingelheim Investigational Site
-
Wonju、大韩民国
- 1245.25.82028 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Feldkirch、奥地利
- 1245.25.43008 Boehringer Ingelheim Investigational Site
-
Graz、奥地利
- 1245.25.43006 Boehringer Ingelheim Investigational Site
-
Innsbruck、奥地利
- 1245.25.43016 Boehringer Ingelheim Investigational Site
-
Salzburg、奥地利
- 1245.25.43005 Boehringer Ingelheim Investigational Site
-
St. Stefan、奥地利
- 1245.25.43015 Boehringer Ingelheim Investigational Site
-
Wien、奥地利
- 1245.25.43001 Boehringer Ingelheim Investigational Site
-
Wien、奥地利
- 1245.25.43007 Boehringer Ingelheim Investigational Site
-
Wien、奥地利
- 1245.25.43009 Boehringer Ingelheim Investigational Site
-
Wien、奥地利
- 1245.25.43010 Boehringer Ingelheim Investigational Site
-
Wien、奥地利
- 1245.25.43013 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Belo Horizonte、巴西
- 1245.25.55019 Boehringer Ingelheim Investigational Site
-
Belém、巴西
- 1245.25.55014 Boehringer Ingelheim Investigational Site
-
Boqueirão、巴西
- 1245.25.55007 Boehringer Ingelheim Investigational Site
-
Brasília、巴西
- 1245.25.55015 Boehringer Ingelheim Investigational Site
-
Campinas、巴西
- 1245.25.55027 Boehringer Ingelheim Investigational Site
-
Campinas、巴西
- 1245.25.55028 Boehringer Ingelheim Investigational Site
-
Curitiba、巴西
- 1245.25.55025 Boehringer Ingelheim Investigational Site
-
Fortaleza、巴西
- 1245.25.55026 Boehringer Ingelheim Investigational Site
-
Goiânia、巴西
- 1245.25.55009 Boehringer Ingelheim Investigational Site
-
Higienópolis、巴西
- 1245.25.55002 Boehringer Ingelheim Investigational Site
-
Marilia、巴西
- 1245.25.55017 Boehringer Ingelheim Investigational Site
-
Maringá、巴西
- 1245.25.55022 Boehringer Ingelheim Investigational Site
-
Porto Alegre、巴西
- 1245.25.55008 Boehringer Ingelheim Investigational Site
-
Porto Alegre、巴西
- 1245.25.55016 Boehringer Ingelheim Investigational Site
-
Porto Alegre、巴西
- 1245.25.55020 Boehringer Ingelheim Investigational Site
-
Ribeirão Preto、巴西
- 1245.25.55012 Boehringer Ingelheim Investigational Site
-
São José do Rio Preto、巴西
- 1245.25.55013 Boehringer Ingelheim Investigational Site
-
São Paulo、巴西
- 1245.25.55004 Boehringer Ingelheim Investigational Site
-
São Paulo、巴西
- 1245.25.55010 Boehringer Ingelheim Investigational Site
-
São Paulo、巴西
- 1245.25.55018 Boehringer Ingelheim Investigational Site
-
São Paulo、巴西
- 1245.25.55023 Boehringer Ingelheim Investigational Site
-
Vila Albuquerque、巴西
- 1245.25.55006 Boehringer Ingelheim Investigational Site
-
Vila Clementino、巴西
- 1245.25.55003 Boehringer Ingelheim Investigational Site
-
Vila Leopoldina、巴西
- 1245.25.55005 Boehringer Ingelheim Investigational Site
-
Villa Clementino、巴西
- 1245.25.55001 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Athens、希腊
- 1245.25.30002 Boehringer Ingelheim Investigational Site
-
Athens、希腊
- 1245.25.30003 Boehringer Ingelheim Investigational Site
-
Athens、希腊
- 1245.25.30004 Boehringer Ingelheim Investigational Site
-
Athens、希腊
- 1245.25.30007 Boehringer Ingelheim Investigational Site
-
Larissa、希腊
- 1245.25.30005 Boehringer Ingelheim Investigational Site
-
Nikaia、希腊
- 1245.25.30001 Boehringer Ingelheim Investigational Site
-
Thessaloniki、希腊
- 1245.25.30006 Boehringer Ingelheim Investigational Site
-
Thessaloniki、希腊
- 1245.25.30008 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Bologna、意大利
- 1245.25.39007 Boehringer Ingelheim Investigational Site
-
Campobasso、意大利
- 1245.25.39002 Boehringer Ingelheim Investigational Site
-
Catanzaro、意大利
- 1245.25.39008 Boehringer Ingelheim Investigational Site
-
Chieti、意大利
- 1245.25.39010 Boehringer Ingelheim Investigational Site
-
Ferrara、意大利
- 1245.25.39024 Boehringer Ingelheim Investigational Site
-
Firenze、意大利
- 1245.25.39009 Boehringer Ingelheim Investigational Site
-
Foggia、意大利
- 1245.25.39005 Boehringer Ingelheim Investigational Site
-
Napoli、意大利
- 1245.25.39004 Boehringer Ingelheim Investigational Site
-
Padova、意大利
- 1245.25.39006 Boehringer Ingelheim Investigational Site
-
Pisa、意大利
- 1245.25.39001 Boehringer Ingelheim Investigational Site
-
Roma、意大利
- 1245.25.39003 Boehringer Ingelheim Investigational Site
-
Roma、意大利
- 1245.25.39011 Boehringer Ingelheim Investigational Site
-
Roma、意大利
- 1245.25.39012 Boehringer Ingelheim Investigational Site
-
Roma、意大利
- 1245.25.39014 Boehringer Ingelheim Investigational Site
-
Venezia、意大利
- 1245.25.39013 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Fornebu、挪威
- 1245.25.47002 Boehringer Ingelheim Investigational Site
-
Gjøvik、挪威
- 1245.25.47004 Boehringer Ingelheim Investigational Site
-
Kløfta、挪威
- 1245.25.47009 Boehringer Ingelheim Investigational Site
-
Kongsvinger、挪威
- 1245.25.47008 Boehringer Ingelheim Investigational Site
-
Oslo、挪威
- 1245.25.47001 Boehringer Ingelheim Investigational Site
-
Oslo、挪威
- 1245.25.47006 Boehringer Ingelheim Investigational Site
-
Trondheim、挪威
- 1245.25.47007 Boehringer Ingelheim Investigational Site
-
Tynset、挪威
- 1245.25.47005 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Brno、捷克共和国
- 1245.25.42020 Boehringer Ingelheim Investigational Site
-
Jindrichuv Hradec、捷克共和国
- 1245.25.42018 Boehringer Ingelheim Investigational Site
-
Praha 3、捷克共和国
- 1245.25.42015 Boehringer Ingelheim Investigational Site
-
Usti nad Labem、捷克共和国
- 1245.25.42019 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Colombo、斯里兰卡
- 1245.25.94002 Boehringer Ingelheim Investigational Site
-
Kalubowila、斯里兰卡
- 1245.25.94005 Boehringer Ingelheim Investigational Site
-
Kandy、斯里兰卡
- 1245.25.94004 Boehringer Ingelheim Investigational Site
-
Kandy、斯里兰卡
- 1245.25.94006 Boehringer Ingelheim Investigational Site
-
Nugegoda、斯里兰卡
- 1245.25.94001 Boehringer Ingelheim Investigational Site
-
Ragama、斯里兰卡
- 1245.25.94003 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Singapore、新加坡
- 1245.25.65001 Boehringer Ingelheim Investigational Site
-
Singapore、新加坡
- 1245.25.65003 Boehringer Ingelheim Investigational Site
-
Singapore、新加坡
- 1245.25.65004 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Christchurch、新西兰
- 1245.25.64004 Boehringer Ingelheim Investigational Site
-
Grafton / Auckland、新西兰
- 1245.25.64001 Boehringer Ingelheim Investigational Site
-
Wellington、新西兰
- 1245.25.64003 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Chuo-ku, tokyo、日本
- 1245.25.81008 Boehringer Ingelheim Investigational Site
-
Gifushi, Gifu、日本
- 1245.25.81010 Boehringer Ingelheim Investigational Site
-
Hanyushi, Saitama、日本
- 1245.25.81002 Boehringer Ingelheim Investigational Site
-
Kamigyo-ku, Kyotoshi, Kyoto、日本
- 1245.25.81013 Boehringer Ingelheim Investigational Site
-
Kishiwadashi. Osaka、日本
- 1245.25.81003 Boehringer Ingelheim Investigational Site
-
Kita-ku, Nagoyashi, Aichi、日本
- 1245.25.81012 Boehringer Ingelheim Investigational Site
-
Kumamoto-shi, Kumamoto、日本
- 1245.25.81014 Boehringer Ingelheim Investigational Site
-
Matsudoshi, Chiba、日本
- 1245.25.81001 Boehringer Ingelheim Investigational Site
-
Mitoshi, Ibaraki、日本
- 1245.25.81006 Boehringer Ingelheim Investigational Site
-
Nishi-ku, Sapporoshi, Hokkaido、日本
- 1245.25.81005 Boehringer Ingelheim Investigational Site
-
Nodashi, Chiba、日本
- 1245.25.81007 Boehringer Ingelheim Investigational Site
-
Shimajiri-gun,Okinawa、日本
- 1245.25.81004 Boehringer Ingelheim Investigational Site
-
Toyamashi, Toyama、日本
- 1245.25.81009 Boehringer Ingelheim Investigational Site
-
Toyoakeshi, Aichi、日本
- 1245.25.81015 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Bonheiden、比利时
- 1245.25.32010 Boehringer Ingelheim Investigational Site
-
Brussel、比利时
- 1245.25.32030 Boehringer Ingelheim Investigational Site
-
Bruxelles、比利时
- 1245.25.32008 Boehringer Ingelheim Investigational Site
-
Bruxelles、比利时
- 1245.25.32011 Boehringer Ingelheim Investigational Site
-
De Pinte、比利时
- 1245.25.32003 Boehringer Ingelheim Investigational Site
-
Edegem、比利时
- 1245.25.32002 Boehringer Ingelheim Investigational Site
-
Genk、比利时
- 1245.25.32004 Boehringer Ingelheim Investigational Site
-
Halen、比利时
- 1245.25.32029 Boehringer Ingelheim Investigational Site
-
Hasselt、比利时
- 1245.25.32009 Boehringer Ingelheim Investigational Site
-
Huy、比利时
- 1245.25.32007 Boehringer Ingelheim Investigational Site
-
La Louvière、比利时
- 1245.25.32013 Boehringer Ingelheim Investigational Site
-
Leuven、比利时
- 1245.25.32012 Boehringer Ingelheim Investigational Site
-
Liège、比利时
- 1245.25.32001 Boehringer Ingelheim Investigational Site
-
Liège、比利时
- 1245.25.32028 Boehringer Ingelheim Investigational Site
-
Massemen-Wetteren、比利时
- 1245.25.32005 Boehringer Ingelheim Investigational Site
-
Oostham、比利时
- 1245.25.32014 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Amiens、法国
- 1245.25.33022 Boehringer Ingelheim Investigational Site
-
Angers、法国
- 1245.25.33033 Boehringer Ingelheim Investigational Site
-
Angers、法国
- 1245.25.33034 Boehringer Ingelheim Investigational Site
-
Bourg des cptes、法国
- 1245.25.33030 Boehringer Ingelheim Investigational Site
-
Corbeil Essonnes、法国
- 1245.25.33023 Boehringer Ingelheim Investigational Site
-
Derval、法国
- 1245.25.33024 Boehringer Ingelheim Investigational Site
-
Equeurdreville Haineville、法国
- 1245.25.33029 Boehringer Ingelheim Investigational Site
-
Fleury sur Orne、法国
- 1245.25.33027 Boehringer Ingelheim Investigational Site
-
Grenoble、法国
- 1245.25.33021 Boehringer Ingelheim Investigational Site
-
La Rochelle Cedex 1、法国
- 1245.25.33003 Boehringer Ingelheim Investigational Site
-
Le Creusot、法国
- 1245.25.33032 Boehringer Ingelheim Investigational Site
-
Narbonne Cedex、法国
- 1245.25.33004 Boehringer Ingelheim Investigational Site
-
Pessac、法国
- 1245.25.33047 Boehringer Ingelheim Investigational Site
-
Poitiers、法国
- 1245.25.33046 Boehringer Ingelheim Investigational Site
-
Saint Priez en Jarez、法国
- 1245.25.33025 Boehringer Ingelheim Investigational Site
-
Tours、法国
- 1245.25.33035 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Gdansk、波兰
- 1245.25.48013 Boehringer Ingelheim Investigational Site
-
Lodz、波兰
- 1245.25.48004 Boehringer Ingelheim Investigational Site
-
Lodz、波兰
- 1245.25.48009 Boehringer Ingelheim Investigational Site
-
Lodz、波兰
- 1245.25.48010 Boehringer Ingelheim Investigational Site
-
Lublin、波兰
- 1245.25.48001 Boehringer Ingelheim Investigational Site
-
Oswiecim、波兰
- 1245.25.48014 Boehringer Ingelheim Investigational Site
-
Poznan、波兰
- 1245.25.48002 Boehringer Ingelheim Investigational Site
-
Pulawy、波兰
- 1245.25.48008 Boehringer Ingelheim Investigational Site
-
Ruda Slaska、波兰
- 1245.25.48007 Boehringer Ingelheim Investigational Site
-
Torun、波兰
- 1245.25.48005 Boehringer Ingelheim Investigational Site
-
Torun、波兰
- 1245.25.48011 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Bangkok、泰国
- 1245.25.66006 Boehringer Ingelheim Investigational Site
-
Bangkok、泰国
- 1245.25.66007 Boehringer Ingelheim Investigational Site
-
Chiang Mai、泰国
- 1245.25.66009 Boehringer Ingelheim Investigational Site
-
Muang District、泰国
- 1245.25.66004 Boehringer Ingelheim Investigational Site
-
Nakhonratchasima、泰国
- 1245.25.66010 Boehringer Ingelheim Investigational Site
-
Pathum Tani、泰国
- 1245.25.66011 Boehringer Ingelheim Investigational Site
-
-
-
-
Queensland
-
Herston、Queensland、澳大利亚
- 1245.25.61003 Boehringer Ingelheim Investigational Site
-
-
South Australia
-
Ashford、South Australia、澳大利亚
- 1245.25.61001 Boehringer Ingelheim Investigational Site
-
Fullarton、South Australia、澳大利亚
- 1245.25.61002 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Tallin、爱沙尼亚
- 1245.25.37002 Boehringer Ingelheim Investigational Site
-
Tallin、爱沙尼亚
- 1245.25.37005 Boehringer Ingelheim Investigational Site
-
Tallinn、爱沙尼亚
- 1245.25.37003 Boehringer Ingelheim Investigational Site
-
Tartu、爱沙尼亚
- 1245.25.37001 Boehringer Ingelheim Investigational Site
-
Tartu、爱沙尼亚
- 1245.25.37004 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Arequipa、秘鲁
- 1245.25.51001 Boehringer Ingelheim Investigational Site
-
Arequipa、秘鲁
- 1245.25.51008 Boehringer Ingelheim Investigational Site
-
Bellavista、秘鲁
- 1245.25.51002 Boehringer Ingelheim Investigational Site
-
El Agustino、秘鲁
- 1245.25.51004 Boehringer Ingelheim Investigational Site
-
Ica、秘鲁
- 1245.25.51006 Boehringer Ingelheim Investigational Site
-
Jesus Maria、秘鲁
- 1245.25.51003 Boehringer Ingelheim Investigational Site
-
Lima、秘鲁
- 1245.25.51007 Boehringer Ingelheim Investigational Site
-
Lima、秘鲁
- 1245.25.51009 Boehringer Ingelheim Investigational Site
-
Lima、秘鲁
- 1245.25.51010 Boehringer Ingelheim Investigational Site
-
Lima、秘鲁
- 1245.25.51011 Boehringer Ingelheim Investigational Site
-
Miraflores、秘鲁
- 1245.25.51005 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Alba Iulia、罗马尼亚
- 1245.25.40008 Boehringer Ingelheim Investigational Site
-
Baia Mare Maramures、罗马尼亚
- 1245.25.40011 Boehringer Ingelheim Investigational Site
-
Bucharest、罗马尼亚
- 1245.25.40003 Boehringer Ingelheim Investigational Site
-
Bucharest、罗马尼亚
- 1245.25.40007 Boehringer Ingelheim Investigational Site
-
Constanta、罗马尼亚
- 1245.25.40005 Boehringer Ingelheim Investigational Site
-
Craiova、罗马尼亚
- 1245.25.40002 Boehringer Ingelheim Investigational Site
-
Craiova、罗马尼亚
- 1245.25.40006 Boehringer Ingelheim Investigational Site
-
Oradea、罗马尼亚
- 1245.25.40009 Boehringer Ingelheim Investigational Site
-
Targu-Mures、罗马尼亚
- 1245.25.40010 Boehringer Ingelheim Investigational Site
-
-
-
-
Alabama
-
Birmingham、Alabama、美国
- 1245.25.10043 Boehringer Ingelheim Investigational Site
-
Birmingham、Alabama、美国
- 1245.25.10121 Boehringer Ingelheim Investigational Site
-
Huntsville、Alabama、美国
- 1245.25.10037 Boehringer Ingelheim Investigational Site
-
Mobile、Alabama、美国
- 1245.25.10124 Boehringer Ingelheim Investigational Site
-
-
Alaska
-
Little Rock、Alaska、美国
- 1245.25.10015 Boehringer Ingelheim Investigational Site
-
-
Arizona
-
Gilbert、Arizona、美国
- 1245.25.10056 Boehringer Ingelheim Investigational Site
-
Peoria、Arizona、美国
- 1245.25.10175 Boehringer Ingelheim Investigational Site
-
Phoenix、Arizona、美国
- 1245.25.10072 Boehringer Ingelheim Investigational Site
-
-
Arkansas
-
Harrisburg、Arkansas、美国
- 1245.25.10048 Boehringer Ingelheim Investigational Site
-
-
California
-
Anaheim、California、美国
- 1245.25.10035 Boehringer Ingelheim Investigational Site
-
Encino、California、美国
- 1245.25.10103 Boehringer Ingelheim Investigational Site
-
Fresno、California、美国
- 1245.25.10158 Boehringer Ingelheim Investigational Site
-
Harbor City、California、美国
- 1245.25.10126 Boehringer Ingelheim Investigational Site
-
Huntington Park、California、美国
- 1245.25.10058 Boehringer Ingelheim Investigational Site
-
Lancaster、California、美国
- 1245.25.10001 Boehringer Ingelheim Investigational Site
-
Los Angeles、California、美国
- 1245.25.10102 Boehringer Ingelheim Investigational Site
-
Los Gatos、California、美国
- 1245.25.10047 Boehringer Ingelheim Investigational Site
-
Palm Springs、California、美国
- 1245.25.10118 Boehringer Ingelheim Investigational Site
-
Riverside、California、美国
- 1245.25.10061 Boehringer Ingelheim Investigational Site
-
San Diego、California、美国
- 1245.25.10040 Boehringer Ingelheim Investigational Site
-
San Diego、California、美国
- 1245.25.10055 Boehringer Ingelheim Investigational Site
-
San Diego、California、美国
- 1245.25.10193 Boehringer Ingelheim Investigational Site
-
Santa Rosa、California、美国
- 1245.25.10027 Boehringer Ingelheim Investigational Site
-
Stockton、California、美国
- 1245.25.10074 Boehringer Ingelheim Investigational Site
-
Valencia、California、美国
- 1245.25.10083 Boehringer Ingelheim Investigational Site
-
-
Colorado
-
Colorado Springs、Colorado、美国
- 1245.25.10144 Boehringer Ingelheim Investigational Site
-
Denver、Colorado、美国
- 1245.25.10085 Boehringer Ingelheim Investigational Site
-
Denver、Colorado、美国
- 1245.25.10153 Boehringer Ingelheim Investigational Site
-
-
Connecticut
-
Norwalk、Connecticut、美国
- 1245.25.10066 Boehringer Ingelheim Investigational Site
-
Waterbury、Connecticut、美国
- 1245.25.10038 Boehringer Ingelheim Investigational Site
-
-
District of Columbia
-
Washington、District of Columbia、美国
- 1245.25.10068 Boehringer Ingelheim Investigational Site
-
-
Florida
-
Bradenton、Florida、美国
- 1245.25.10094 Boehringer Ingelheim Investigational Site
-
Brooksville、Florida、美国
- 1245.25.10190 Boehringer Ingelheim Investigational Site
-
Clearwater、Florida、美国
- 1245.25.10209 Boehringer Ingelheim Investigational Site
-
Cooper City、Florida、美国
- 1245.25.10212 Boehringer Ingelheim Investigational Site
-
Delray Beach、Florida、美国
- 1245.25.10200 Boehringer Ingelheim Investigational Site
-
Ft. Lauderdale、Florida、美国
- 1245.25.10033 Boehringer Ingelheim Investigational Site
-
Hallandale Beach、Florida、美国
- 1245.25.10202 Boehringer Ingelheim Investigational Site
-
Hialeah、Florida、美国
- 1245.25.10062 Boehringer Ingelheim Investigational Site
-
Hialeah、Florida、美国
- 1245.25.10063 Boehringer Ingelheim Investigational Site
-
Hialeah、Florida、美国
- 1245.25.10157 Boehringer Ingelheim Investigational Site
-
Jacksonville、Florida、美国
- 1245.25.10089 Boehringer Ingelheim Investigational Site
-
Longwood、Florida、美国
- 1245.25.10019 Boehringer Ingelheim Investigational Site
-
Maitland、Florida、美国
- 1245.25.10168 Boehringer Ingelheim Investigational Site
-
Miami、Florida、美国
- 1245.25.10018 Boehringer Ingelheim Investigational Site
-
Miami、Florida、美国
- 1245.25.10039 Boehringer Ingelheim Investigational Site
-
Miami、Florida、美国
- 1245.25.10184 Boehringer Ingelheim Investigational Site
-
Orlando、Florida、美国
- 1245.25.10123 Boehringer Ingelheim Investigational Site
-
Orlando、Florida、美国
- 1245.25.10201 Boehringer Ingelheim Investigational Site
-
Pembroke Pines、Florida、美国
- 1245.25.10025 Boehringer Ingelheim Investigational Site
-
Pembroke Pines、Florida、美国
- 1245.25.10042 Boehringer Ingelheim Investigational Site
-
Port Charlotte、Florida、美国
- 1245.25.10147 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、Florida、美国
- 1245.25.10198 Boehringer Ingelheim Investigational Site
-
Saint Petersburg、Florida、美国
- 1245.25.10203 Boehringer Ingelheim Investigational Site
-
Tampa、Florida、美国
- 1245.25.10104 Boehringer Ingelheim Investigational Site
-
Tampa、Florida、美国
- 1245.25.10178 Boehringer Ingelheim Investigational Site
-
Tampa、Florida、美国
- 1245.25.10211 Boehringer Ingelheim Investigational Site
-
-
Georgia
-
Atlanta、Georgia、美国
- 1245.25.10023 Boehringer Ingelheim Investigational Site
-
Columbus、Georgia、美国
- 1245.25.10174 Boehringer Ingelheim Investigational Site
-
Riverdale、Georgia、美国
- 1245.25.10141 Boehringer Ingelheim Investigational Site
-
Roswell、Georgia、美国
- 1245.25.10067 Boehringer Ingelheim Investigational Site
-
-
Hawaii
-
Honolulu、Hawaii、美国
- 1245.25.10022 Boehringer Ingelheim Investigational Site
-
-
Idaho
-
Boise、Idaho、美国
- 1245.25.10092 Boehringer Ingelheim Investigational Site
-
-
Illinois
-
Chicago、Illinois、美国
- 1245.25.10097 Boehringer Ingelheim Investigational Site
-
-
Indiana
-
Evansville、Indiana、美国
- 1245.25.10116 Boehringer Ingelheim Investigational Site
-
Valparaiso、Indiana、美国
- 1245.25.10206 Boehringer Ingelheim Investigational Site
-
-
Kansas
-
Wichita、Kansas、美国
- 1245.25.10021 Boehringer Ingelheim Investigational Site
-
-
Kentucky
-
Lexington、Kentucky、美国
- 1245.25.10186 Boehringer Ingelheim Investigational Site
-
Louisville、Kentucky、美国
- 1245.25.10109 Boehringer Ingelheim Investigational Site
-
Madisonville、Kentucky、美国
- 1245.25.10006 Boehringer Ingelheim Investigational Site
-
Paducah、Kentucky、美国
- 1245.25.10005 Boehringer Ingelheim Investigational Site
-
-
Louisiana
-
New Orleans、Louisiana、美国
- 1245.25.10020 Boehringer Ingelheim Investigational Site
-
-
Maine
-
Auburn、Maine、美国
- 1245.25.10012 Boehringer Ingelheim Investigational Site
-
-
Maryland
-
Baltimore、Maryland、美国
- 1245.25.10041 Boehringer Ingelheim Investigational Site
-
Hyattsville、Maryland、美国
- 1245.25.10134 Boehringer Ingelheim Investigational Site
-
Towson、Maryland、美国
- 1245.25.10210 Boehringer Ingelheim Investigational Site
-
-
Massachusetts
-
Springfield、Massachusetts、美国
- 1245.25.10064 Boehringer Ingelheim Investigational Site
-
Watertown、Massachusetts、美国
- 1245.25.10051 Boehringer Ingelheim Investigational Site
-
-
Michigan
-
Dearborn、Michigan、美国
- 1245.25.10071 Boehringer Ingelheim Investigational Site
-
Flint、Michigan、美国
- 1245.25.10013 Boehringer Ingelheim Investigational Site
-
Petoskey、Michigan、美国
- 1245.25.10107 Boehringer Ingelheim Investigational Site
-
-
Minnesota
-
Eagan、Minnesota、美国
- 1245.25.10030 Boehringer Ingelheim Investigational Site
-
Minneapolis、Minnesota、美国
- 1245.25.10028 Boehringer Ingelheim Investigational Site
-
-
Mississippi
-
Picayune、Mississippi、美国
- 1245.25.10176 Boehringer Ingelheim Investigational Site
-
-
Missouri
-
Chesterfield、Missouri、美国
- 1245.25.10011 Boehringer Ingelheim Investigational Site
-
Kansas City、Missouri、美国
- 1245.25.10163 Boehringer Ingelheim Investigational Site
-
-
Montana
-
Great Falls、Montana、美国
- 1245.25.10148 Boehringer Ingelheim Investigational Site
-
Great Falls、Montana、美国
- 1245.25.10191 Boehringer Ingelheim Investigational Site
-
-
Nebraska
-
Omaha、Nebraska、美国
- 1245.25.10034 Boehringer Ingelheim Investigational Site
-
-
New Jersey
-
Flemington、New Jersey、美国
- 1245.25.10014 Boehringer Ingelheim Investigational Site
-
-
New Mexico
-
Albuquerque、New Mexico、美国
- 1245.25.10145 Boehringer Ingelheim Investigational Site
-
Albuquerque、New Mexico、美国
- 1245.25.10180 Boehringer Ingelheim Investigational Site
-
-
New York
-
Binghamton、New York、美国
- 1245.25.10131 Boehringer Ingelheim Investigational Site
-
Rochester、New York、美国
- 1245.25.10029 Boehringer Ingelheim Investigational Site
-
Smithtown、New York、美国
- 1245.25.10142 Boehringer Ingelheim Investigational Site
-
Staten Island、New York、美国
- 1245.25.10096 Boehringer Ingelheim Investigational Site
-
-
North Carolina
-
Burlington、North Carolina、美国
- 1245.25.10196 Boehringer Ingelheim Investigational Site
-
Calabash、North Carolina、美国
- 1245.25.10207 Boehringer Ingelheim Investigational Site
-
Durham、North Carolina、美国
- 1245.25.10053 Boehringer Ingelheim Investigational Site
-
Greenville、North Carolina、美国
- 1245.25.10010 Boehringer Ingelheim Investigational Site
-
-
Ohio
-
Cincinnati、Ohio、美国
- 1245.25.10060 Boehringer Ingelheim Investigational Site
-
Cincinnati、Ohio、美国
- 1245.25.10086 Boehringer Ingelheim Investigational Site
-
Dayton、Ohio、美国
- 1245.25.10137 Boehringer Ingelheim Investigational Site
-
Delaware、Ohio、美国
- 1245.25.10138 Boehringer Ingelheim Investigational Site
-
Kettering、Ohio、美国
- 1245.25.10156 Boehringer Ingelheim Investigational Site
-
Marion、Ohio、美国
- 1245.25.10091 Boehringer Ingelheim Investigational Site
-
Zanesville、Ohio、美国
- 1245.25.10192 Boehringer Ingelheim Investigational Site
-
-
Oklahoma
-
Norman、Oklahoma、美国
- 1245.25.10114 Boehringer Ingelheim Investigational Site
-
-
Oregon
-
Eugene、Oregon、美国
- 1245.25.10082 Boehringer Ingelheim Investigational Site
-
-
Pennsylvania
-
Clairton、Pennsylvania、美国
- 1245.25.10154 Boehringer Ingelheim Investigational Site
-
Clairton、Pennsylvania、美国
- 1245.25.10173 Boehringer Ingelheim Investigational Site
-
Feasterville Trevose、Pennsylvania、美国
- 1245.25.10052 Boehringer Ingelheim Investigational Site
-
Fleetwood、Pennsylvania、美国
- 1245.25.10069 Boehringer Ingelheim Investigational Site
-
Greensburg、Pennsylvania、美国
- 1245.25.10172 Boehringer Ingelheim Investigational Site
-
Indiana、Pennsylvania、美国
- 1245.25.10050 Boehringer Ingelheim Investigational Site
-
Lansdale、Pennsylvania、美国
- 1245.25.10009 Boehringer Ingelheim Investigational Site
-
Philadelphia、Pennsylvania、美国
- 1245.25.10214 Boehringer Ingelheim Investigational Site
-
Pittsburgh、Pennsylvania、美国
- 1245.25.10149 Boehringer Ingelheim Investigational Site
-
Pittsburgh、Pennsylvania、美国
- 1245.25.10197 Boehringer Ingelheim Investigational Site
-
Scottdale、Pennsylvania、美国
- 1245.25.10159 Boehringer Ingelheim Investigational Site
-
Tipton、Pennsylvania、美国
- 1245.25.10162 Boehringer Ingelheim Investigational Site
-
Uniontown、Pennsylvania、美国
- 1245.25.10146 Boehringer Ingelheim Investigational Site
-
Yardley、Pennsylvania、美国
- 1245.25.10077 Boehringer Ingelheim Investigational Site
-
-
South Carolina
-
Anderson、South Carolina、美国
- 1245.25.10070 Boehringer Ingelheim Investigational Site
-
Charleston、South Carolina、美国
- 1245.25.10044 Boehringer Ingelheim Investigational Site
-
Greer、South Carolina、美国
- 1245.25.10002 Boehringer Ingelheim Investigational Site
-
Hodges、South Carolina、美国
- 1245.25.10132 Boehringer Ingelheim Investigational Site
-
Mt. Pleasant、South Carolina、美国
- 1245.25.10140 Boehringer Ingelheim Investigational Site
-
Myrtle Beach、South Carolina、美国
- 1245.25.10065 Boehringer Ingelheim Investigational Site
-
Myrtle Beach、South Carolina、美国
- 1245.25.10127 Boehringer Ingelheim Investigational Site
-
North Myrtle Beach、South Carolina、美国
- 1245.25.10170 Boehringer Ingelheim Investigational Site
-
Spartanburg、South Carolina、美国
- 1245.25.10129 Boehringer Ingelheim Investigational Site
-
Union、South Carolina、美国
- 1245.25.10171 Boehringer Ingelheim Investigational Site
-
-
Tennessee
-
Bristol、Tennessee、美国
- 1245.25.10054 Boehringer Ingelheim Investigational Site
-
Chattanooga、Tennessee、美国
- 1245.25.10036 Boehringer Ingelheim Investigational Site
-
Chattanooga、Tennessee、美国
- 1245.25.10057 Boehringer Ingelheim Investigational Site
-
Kingsport、Tennessee、美国
- 1245.25.10046 Boehringer Ingelheim Investigational Site
-
Memphis、Tennessee、美国
- 1245.25.10143 Boehringer Ingelheim Investigational Site
-
-
Texas
-
Corpus Christi、Texas、美国
- 1245.25.10075 Boehringer Ingelheim Investigational Site
-
Dallas、Texas、美国
- 1245.25.10007 Boehringer Ingelheim Investigational Site
-
Dallas、Texas、美国
- 1245.25.10026 Boehringer Ingelheim Investigational Site
-
Dallas、Texas、美国
- 1245.25.10100 Boehringer Ingelheim Investigational Site
-
Dallas、Texas、美国
- 1245.25.10165 Boehringer Ingelheim Investigational Site
-
Fort Worth、Texas、美国
- 1245.25.10169 Boehringer Ingelheim Investigational Site
-
Houston、Texas、美国
- 1245.25.10003 Boehringer Ingelheim Investigational Site
-
Houston、Texas、美国
- 1245.25.10125 Boehringer Ingelheim Investigational Site
-
Houston、Texas、美国
- 1245.25.10189 Boehringer Ingelheim Investigational Site
-
Lubbock、Texas、美国
- 1245.25.10119 Boehringer Ingelheim Investigational Site
-
New Braunfels、Texas、美国
- 1245.25.10078 Boehringer Ingelheim Investigational Site
-
Odessa、Texas、美国
- 1245.25.10076 Boehringer Ingelheim Investigational Site
-
Pearland、Texas、美国
- 1245.25.10133 Boehringer Ingelheim Investigational Site
-
Plano、Texas、美国
- 1245.25.10160 Boehringer Ingelheim Investigational Site
-
Richardson、Texas、美国
- 1245.25.10177 Boehringer Ingelheim Investigational Site
-
San Antonio、Texas、美国
- 1245.25.10049 Boehringer Ingelheim Investigational Site
-
San Antonio、Texas、美国
- 1245.25.10161 Boehringer Ingelheim Investigational Site
-
-
Utah
-
Bountiful、Utah、美国
- 1245.25.10185 Boehringer Ingelheim Investigational Site
-
Draper、Utah、美国
- 1245.25.10155 Boehringer Ingelheim Investigational Site
-
Midvale、Utah、美国
- 1245.25.10079 Boehringer Ingelheim Investigational Site
-
Salt Lake City、Utah、美国
- 1245.25.10080 Boehringer Ingelheim Investigational Site
-
South Ogden、Utah、美国
- 1245.25.10087 Boehringer Ingelheim Investigational Site
-
-
Virginia
-
Burke、Virginia、美国
- 1245.25.10218 Boehringer Ingelheim Investigational Site
-
Norfolk、Virginia、美国
- 1245.25.10004 Boehringer Ingelheim Investigational Site
-
South Chesterfield、Virginia、美国
- 1245.25.10111 Boehringer Ingelheim Investigational Site
-
-
Washington
-
Spokane、Washington、美国
- 1245.25.10115 Boehringer Ingelheim Investigational Site
-
Spokane、Washington、美国
- 1245.25.10216 Boehringer Ingelheim Investigational Site
-
Tacoma、Washington、美国
- 1245.25.10017 Boehringer Ingelheim Investigational Site
-
Walla Walla、Washington、美国
- 1245.25.10016 Boehringer Ingelheim Investigational Site
-
-
West Virginia
-
Charleston、West Virginia、美国
- 1245.25.10187 Boehringer Ingelheim Investigational Site
-
Morgantown、West Virginia、美国
- 1245.25.10182 Boehringer Ingelheim Investigational Site
-
-
Wisconsin
-
Madison、Wisconsin、美国
- 1245.25.10098 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Airdrie、英国
- 1245.25.44045 Boehringer Ingelheim Investigational Site
-
Ashford、英国
- 1245.25.44020 Boehringer Ingelheim Investigational Site
-
Blackpool、英国
- 1245.25.44013 Boehringer Ingelheim Investigational Site
-
Bolton、英国
- 1245.25.44014 Boehringer Ingelheim Investigational Site
-
Bradford on Avon、英国
- 1245.25.44021 Boehringer Ingelheim Investigational Site
-
Dumfries、英国
- 1245.25.44002 Boehringer Ingelheim Investigational Site
-
Dundee、英国
- 1245.25.44009 Boehringer Ingelheim Investigational Site
-
Edinburgh、英国
- 1245.25.44005 Boehringer Ingelheim Investigational Site
-
Fowey、英国
- 1245.25.44004 Boehringer Ingelheim Investigational Site
-
Frome、英国
- 1245.25.44001 Boehringer Ingelheim Investigational Site
-
Inverness、英国
- 1245.25.44003 Boehringer Ingelheim Investigational Site
-
Wishaw、英国
- 1245.25.44044 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Amersfoort、荷兰
- 1245.25.31015 Boehringer Ingelheim Investigational Site
-
Apeldoorn、荷兰
- 1245.25.31013 Boehringer Ingelheim Investigational Site
-
Baarle - Nassau、荷兰
- 1245.25.31036 Boehringer Ingelheim Investigational Site
-
Delft、荷兰
- 1245.25.31032 Boehringer Ingelheim Investigational Site
-
Den Helder、荷兰
- 1245.25.31026 Boehringer Ingelheim Investigational Site
-
Geleen、荷兰
- 1245.25.31012 Boehringer Ingelheim Investigational Site
-
Hardenberg、荷兰
- 1245.25.31017 Boehringer Ingelheim Investigational Site
-
Heerlen、荷兰
- 1245.25.31035 Boehringer Ingelheim Investigational Site
-
Hoogeveen、荷兰
- 1245.25.31011 Boehringer Ingelheim Investigational Site
-
Hoogezand、荷兰
- 1245.25.31029 Boehringer Ingelheim Investigational Site
-
Hoogwoud、荷兰
- 1245.25.31023 Boehringer Ingelheim Investigational Site
-
Maastricht、荷兰
- 1245.25.31009 Boehringer Ingelheim Investigational Site
-
Meppel、荷兰
- 1245.25.31031 Boehringer Ingelheim Investigational Site
-
Nijverdal、荷兰
- 1245.25.31024 Boehringer Ingelheim Investigational Site
-
Rotterdam、荷兰
- 1245.25.31014 Boehringer Ingelheim Investigational Site
-
Rotterdam、荷兰
- 1245.25.31033 Boehringer Ingelheim Investigational Site
-
Schiedam、荷兰
- 1245.25.31030 Boehringer Ingelheim Investigational Site
-
Utrecht、荷兰
- 1245.25.31002 Boehringer Ingelheim Investigational Site
-
Wildervank、荷兰
- 1245.25.31028 Boehringer Ingelheim Investigational Site
-
Zutphen、荷兰
- 1245.25.31034 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Cavite City、菲律宾
- 1245.25.63016 Boehringer Ingelheim Investigational Site
-
Cebu、菲律宾
- 1245.25.63002 Boehringer Ingelheim Investigational Site
-
Davao、菲律宾
- 1245.25.63003 Boehringer Ingelheim Investigational Site
-
Jaro Iloilo City、菲律宾
- 1245.25.63020 Boehringer Ingelheim Investigational Site
-
Manila、菲律宾
- 1245.25.63001 Boehringer Ingelheim Investigational Site
-
Manila、菲律宾
- 1245.25.63004 Boehringer Ingelheim Investigational Site
-
Manila、菲律宾
- 1245.25.63018 Boehringer Ingelheim Investigational Site
-
Marikina City、菲律宾
- 1245.25.63009 Boehringer Ingelheim Investigational Site
-
Marikina City、菲律宾
- 1245.25.63021 Boehringer Ingelheim Investigational Site
-
Tarlac、菲律宾
- 1245.25.63019 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Amadora、葡萄牙
- 1245.25.35006 Boehringer Ingelheim Investigational Site
-
Coimbra、葡萄牙
- 1245.25.35004 Boehringer Ingelheim Investigational Site
-
Faro、葡萄牙
- 1245.25.35018 Boehringer Ingelheim Investigational Site
-
Funchal、葡萄牙
- 1245.25.35021 Boehringer Ingelheim Investigational Site
-
Leiria、葡萄牙
- 1245.25.35008 Boehringer Ingelheim Investigational Site
-
Lisboa、葡萄牙
- 1245.25.35001 Boehringer Ingelheim Investigational Site
-
Lisboa、葡萄牙
- 1245.25.35002 Boehringer Ingelheim Investigational Site
-
Lisboa、葡萄牙
- 1245.25.35015 Boehringer Ingelheim Investigational Site
-
Lisboa、葡萄牙
- 1245.25.35017 Boehringer Ingelheim Investigational Site
-
Porto、葡萄牙
- 1245.25.35011 Boehringer Ingelheim Investigational Site
-
Santiago do Cacém、葡萄牙
- 1245.25.35005 Boehringer Ingelheim Investigational Site
-
Torres Novas、葡萄牙
- 1245.25.35020 Boehringer Ingelheim Investigational Site
-
Viana do Castelo、葡萄牙
- 1245.25.35014 Boehringer Ingelheim Investigational Site
-
Vila Nova de Gaia、葡萄牙
- 1245.25.35019 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Alcorcon (Madrid)、西班牙
- 1245.25.34025 Boehringer Ingelheim Investigational Site
-
Alicante、西班牙
- 1245.25.34048 Boehringer Ingelheim Investigational Site
-
Alzira、西班牙
- 1245.25.34050 Boehringer Ingelheim Investigational Site
-
Avila、西班牙
- 1245.25.34039 Boehringer Ingelheim Investigational Site
-
Badía del Vallès - Barcelona、西班牙
- 1245.25.34040 Boehringer Ingelheim Investigational Site
-
Barcelona、西班牙
- 1245.25.34029 Boehringer Ingelheim Investigational Site
-
Barcelona、西班牙
- 1245.25.34030 Boehringer Ingelheim Investigational Site
-
Barcelona、西班牙
- 1245.25.34049 Boehringer Ingelheim Investigational Site
-
Granada、西班牙
- 1245.25.34031 Boehringer Ingelheim Investigational Site
-
Leganes (Madrid)、西班牙
- 1245.25.34024 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34013 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34023 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34026 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34028 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34033 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34036 Boehringer Ingelheim Investigational Site
-
Madrid、西班牙
- 1245.25.34038 Boehringer Ingelheim Investigational Site
-
Mahadahonda (Madrid)、西班牙
- 1245.25.34022 Boehringer Ingelheim Investigational Site
-
Palma de Mallorca、西班牙
- 1245.25.34047 Boehringer Ingelheim Investigational Site
-
Sabadell (Barcelona)、西班牙
- 1245.25.34034 Boehringer Ingelheim Investigational Site
-
Salamanca、西班牙
- 1245.25.34027 Boehringer Ingelheim Investigational Site
-
Santa Cruz de Tenerife、西班牙
- 1245.25.34037 Boehringer Ingelheim Investigational Site
-
Segovia、西班牙
- 1245.25.34046 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Buenos Aires、阿根廷
- 1245.25.54012 Boehringer Ingelheim Investigational Site
-
Capital Federal、阿根廷
- 1245.25.54001 Boehringer Ingelheim Investigational Site
-
Capital Federal、阿根廷
- 1245.25.54006 Boehringer Ingelheim Investigational Site
-
Capital Federal、阿根廷
- 1245.25.54013 Boehringer Ingelheim Investigational Site
-
Cordoba、阿根廷
- 1245.25.54010 Boehringer Ingelheim Investigational Site
-
Cordoba、阿根廷
- 1245.25.54011 Boehringer Ingelheim Investigational Site
-
Córdoba、阿根廷
- 1245.25.54002 Boehringer Ingelheim Investigational Site
-
Córdoba、阿根廷
- 1245.25.54003 Boehringer Ingelheim Investigational Site
-
Parque Velez Sarfield、阿根廷
- 1245.25.54005 Boehringer Ingelheim Investigational Site
-
Rosario、阿根廷
- 1245.25.54008 Boehringer Ingelheim Investigational Site
-
Rosario、阿根廷
- 1245.25.54009 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Hong Kong、香港
- 1245.25.85201 Boehringer Ingelheim Investigational Site
-
Hong Kong、香港
- 1245.25.85205 Boehringer Ingelheim Investigational Site
-
Hong Kong、香港
- 1245.25.85207 Boehringer Ingelheim Investigational Site
-
Hong Kong、香港
- 1245.25.85208 Boehringer Ingelheim Investigational Site
-
-
-
-
-
Johor Bahru、马来西亚
- 1245.25.60019 Boehringer Ingelheim Investigational Site
-
Kedah、马来西亚
- 1245.25.60020 Boehringer Ingelheim Investigational Site
-
Kelantan、马来西亚
- 1245.25.60013 Boehringer Ingelheim Investigational Site
-
Kota Kinabalu、马来西亚
- 1245.25.60015 Boehringer Ingelheim Investigational Site
-
Kuala Lumpur、马来西亚
- 1245.25.60012 Boehringer Ingelheim Investigational Site
-
Kuala Lumpur、马来西亚
- 1245.25.60017 Boehringer Ingelheim Investigational Site
-
Pahang、马来西亚
- 1245.25.60004 Boehringer Ingelheim Investigational Site
-
Selangor、马来西亚
- 1245.25.60016 Boehringer Ingelheim Investigational Site
-
Selangor、马来西亚
- 1245.25.60021 Boehringer Ingelheim Investigational Site
-
Selangor Darul Ehsan、马来西亚
- 1245.25.60018 Boehringer Ingelheim Investigational Site
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
纳入标准:
- 知情同意前 2 型糖尿病的诊断
- 采用饮食和运动方案的男性或女性患者,他们未接受过药物治疗或预先接受过任何背景治疗。 在随机化之前的 12 周内,抗糖尿病治疗必须保持不变。
- 对于接受背景治疗的患者,糖化血红蛋白 (HbA1c) >= 7.0% 且 <=10%,对于未接受药物治疗的患者,糖化血红蛋白 (HbA1c) >= 7.0% 且 <= 9.0%
- 年龄 >= 18 岁
- 第 1 次访视时体重指数 <= 45
- 签署并注明日期的知情同意书
- 高心血管风险
排除标准:
- 在安慰剂导入期间禁食过夜后血糖水平 >240 mg/dl (>13.3 mmol/L) 且通过第二次测量(不是在同一天)确认的不受控制的高血糖症
- 肝病的指征,定义为丙氨酸转氨酶 (ALT)、天冬氨酸转氨酶 ALT 或碱性磷酸酶的血清水平高于 3 x 正常值上限 (ULN),如筛选和/或试运行时所确定。
- 计划在 3 个月内进行心脏手术或血管成形术
- 肾功能受损,定义为筛选或试运行期间肾小球滤过率 <30 ml/min(严重肾功能损害,肾脏疾病饮食改良配方)。
- 过去两年内的减肥手术和其他引起慢性吸收不良的胃肠道手术
- 血液恶液质或任何引起溶血或红细胞不稳定的疾病(例如 疟疾、巴贝斯虫病、溶血性贫血)
- 过去 5 年内的癌症病史(基底细胞癌除外)和/或癌症治疗
- 根据当地标签进行背景治疗的禁忌症
- 用抗肥胖药物治疗(例如 西布曲明、奥利司他)在知情同意或筛选时的任何其他治疗前 3 个月(即 手术、激进的饮食疗法等)导致体重不稳定
- 在知情同意时正在接受全身性类固醇治疗或在知情同意前 6 周内改变甲状腺激素剂量或除 2 型糖尿病外的任何其他不受控制的内分泌疾病
绝经前妇女(末次月经在知情同意前 <+ 1 年):
- 正在哺乳或怀孕或
- 有生育能力并且没有采用可接受的节育方法,或者不打算在整个研究过程中继续使用这种方法,并且不同意在参与试验期间接受定期妊娠检测。 可接受的节育方法包括输卵管结扎、透皮贴剂、宫内节育器/系统、口服、植入或注射避孕药、禁欲、双屏障法和伴侣输精管切除术
- 在知情同意之前的 3 个月内酗酒或滥用药物会影响试验参与或导致对研究程序或研究药物摄入的依从性降低的任何持续状况
- 在知情同意前 30 天内参与另一项研究药物试验
- 在参加该临床试验时会危及患者安全的任何其他临床情况
- 知情同意前 2 个月内发生急性冠脉综合征、中风或 TIA
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:安慰剂
匹配 BI 10773 的安慰剂药片
|
安慰剂药片与 BI 10773 相同
安慰剂药片与 BI 10773 相同
|
|
实验性的:BI 10773低剂量
BI 10773 片剂,每日一次
|
BI 10773 片剂,每日一次
安慰剂药片与 BI 10773 相同
|
|
实验性的:BI 10773 高剂量
BI 10773 片剂,每日一次
|
BI 10773 片剂,每日一次
安慰剂药片与 BI 10773 相同
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
首次出现主要复合终点(3 点 MACE)的任何以下裁定成分的时间:CV 死亡(包括致死性中风和致死性 MI)、非致死性 MI(不包括无症状 MI)和非致死性中风.
大体时间:从随机化到个体观察结束,长达 4.6 年
|
首次出现主要复合终点(3 点主要不良心血管事件 (MACE))的以下任何裁定组成部分的时间:心血管 (CV) 死亡(包括致死性中风和致死性心肌梗死 (MI))、非致死性 MI(不包括无症状 MI)和非致死性中风。 呈现了发生该事件的患者的百分比。 |
从随机化到个体观察结束,长达 4.6 年
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
已判定所有事件(4 点 MACE)的参与者百分比:CV 死亡(包括致死性中风和致死性 MI)、非致死性 MI(不包括无症状 MI)、非致死性中风和因不稳定型心绞痛住院
大体时间:从随机化到个体观察结束,长达 4.6 年
|
判定的所有事件的复合(4 分 MACE):心血管死亡(包括致死性中风和致死性心肌梗塞)、非致死性心肌梗塞(不包括无症状 MI)、非致死性中风和因不稳定型心绞痛住院。这是一个试验的关键次要终点。 呈现了发生该事件的患者的百分比。 |
从随机化到个体观察结束,长达 4.6 年
|
|
无症状 MI 参与者的百分比
大体时间:从随机化到个体观察结束,长达 4.6 年
|
静音 MI;定义为 ECG 中存在:
还要求在随机化后直至并包括指定的 ECG 测量日期,没有经过裁定和确认的急性 MI、不稳定型心绞痛住院、冠状动脉血运重建手术或支架内血栓形成事件。 呈现了发生该事件的患者的百分比。 |
从随机化到个体观察结束,长达 4.6 年
|
|
需要住院治疗的心力衰竭参与者的百分比(已裁定)
大体时间:从随机化到个体观察结束,长达 4.6 年
|
需要住院治疗的心力衰竭(已裁定)。
呈现了发生该事件的患者的百分比。
|
从随机化到个体观察结束,长达 4.6 年
|
|
新发蛋白尿参与者的百分比
大体时间:从随机化到个体观察结束,长达 4.6 年
|
新发白蛋白尿定义为尿白蛋白/肌酐比值 (UACR) ≥ 30 mg/g。 呈现了发生该事件的患者的百分比。 |
从随机化到个体观察结束,长达 4.6 年
|
|
新发大量白蛋白尿的参与者百分比
大体时间:从随机化到个体观察结束,长达 4.6 年
|
新发大量白蛋白尿定义为 UACR >300 mg/g。
呈现了发生该事件的患者的百分比。
|
从随机化到个体观察结束,长达 4.6 年
|
|
具有复合微血管结果的参与者百分比
大体时间:从随机化到个体观察结束,长达 4.6 年
|
复合微血管结果定义为:
|
从随机化到个体观察结束,长达 4.6 年
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Tuttle KR, Levin A, Nangaku M, Kadowaki T, Agarwal R, Hauske SJ, Elsasser A, Ritter I, Steubl D, Wanner C, Wheeler DC. Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Diabetes Care. 2022 Jun 2;45(6):1445-1452. doi: 10.2337/dc21-2034.
- Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB. Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. Am J Manag Care. 2018 Apr;24(8 Suppl):S138-S145.
- Kahl S, Ofstad AP, Zinman B, Wanner C, Schuler E, Sattar N, Inzucchi SE, Roden M. Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes. Diabetes Obes Metab. 2022 Jun;24(6):1061-1071. doi: 10.1111/dom.14670. Epub 2022 Mar 8.
- Ruggenenti P, Kraus BJ, Inzucchi SE, Zinman B, Hantel S, Mattheus M, von Eynatten M, Remuzzi G, Koitka-Weber A, Wanner C. Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes. EClinicalMedicine. 2021 Dec 24;43:101240. doi: 10.1016/j.eclinm.2021.101240. eCollection 2022 Jan.
- Reifsnider OS, Kansal AR, Wanner C, Pfarr E, Koitka-Weber A, Brand SB, Stargardter M, Wang C, Kuti E, Ustyugova A. Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial. Am J Kidney Dis. 2022 Jun;79(6):796-806. doi: 10.1053/j.ajkd.2021.09.014. Epub 2021 Nov 6.
- Ferreira JP, Inzucchi SE, Mattheus M, Meinicke T, Steubl D, Wanner C, Zinman B. Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes Obes Metab. 2022 Jan;24(1):135-141. doi: 10.1111/dom.14559. Epub 2021 Oct 4.
- Vaduganathan M, Inzucchi SE, Sattar N, Fitchett DH, Ofstad AP, Brueckmann M, George JT, Verma S, Mattheus M, Wanner C, Zinman B, Butler J. Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial. Diabetes Obes Metab. 2021 Dec;23(12):2775-2784. doi: 10.1111/dom.14535. Epub 2021 Oct 7.
- Sharma A, Ofstad AP, Ahmad T, Zinman B, Zwiener I, Fitchett D, Wanner C, George JT, Hantel S, Desai N, Mentz RJ. Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial. JACC Heart Fail. 2021 Aug;9(8):568-577. doi: 10.1016/j.jchf.2021.03.003.
- Cherney DZI, Dagogo-Jack S, McGuire DK, Cosentino F, Pratley R, Shih WJ, Frederich R, Maldonado M, Liu J, Wang S, Cannon CP; VERTIS CV Investigators. Kidney outcomes using a sustained >/=40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials. Clin Cardiol. 2021 Aug;44(8):1139-1143. doi: 10.1002/clc.23665. Epub 2021 Jun 15.
- Ferreira JP, Kraus BJ, Zwiener I, Lauer S, Zinman B, Fitchett DH, Koitka-Weber A, George JT, Ofstad AP, Wanner C, Zannad F. Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial. J Am Heart Assoc. 2021 Apr 6;10(7):e020053. doi: 10.1161/JAHA.120.020053. Epub 2021 Mar 23.
- Ferreira JP, Verma S, Fitchett D, Ofstad AP, Lauer S, Zwiener I, George J, Wanner C, Zinman B, Inzucchi SE. Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial. Cardiovasc Diabetol. 2020 Nov 26;19(1):200. doi: 10.1186/s12933-020-01174-6.
- McGuire DK, Zinman B, Inzucchi SE, Wanner C, Fitchett D, Anker SD, Pocock S, Kaspers S, George JT, von Eynatten M, Johansen OE, Jamal W, Mattheus M, Elsasser U, Hantel S, Lund SS. Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial. Lancet Diabetes Endocrinol. 2020 Dec;8(12):949-959. doi: 10.1016/S2213-8587(20)30344-2.
- Ceriello A, Ofstad AP, Zwiener I, Kaspers S, George J, Nicolucci A. Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial. Cardiovasc Diabetol. 2020 Oct 13;19(1):176. doi: 10.1186/s12933-020-01147-9.
- Neeland IJ, Eliasson B, Kasai T, Marx N, Zinman B, Inzucchi SE, Wanner C, Zwiener I, Wojeck BS, Yaggi HK, Johansen OE; EMPA-REG OUTCOME Investigators. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020 Dec;43(12):3007-3015. doi: 10.2337/dc20-1096. Epub 2020 Oct 1.
- Levin A, Perkovic V, Wheeler DC, Hantel S, George JT, von Eynatten M, Koitka-Weber A, Wanner C; EMPA-REG OUTCOME Investigators. Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial. Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1433-1444. doi: 10.2215/CJN.14901219. Epub 2020 Sep 29.
- Waijer SW, Xie D, Inzucchi SE, Zinman B, Koitka-Weber A, Mattheus M, von Eynatten M, Inker LA, Wanner C, Heerspink HJL. Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial. J Am Heart Assoc. 2020 Sep 15;9(18):e016976. doi: 10.1161/JAHA.120.016976. Epub 2020 Sep 6.
- Bohm M, Fitchett D, Ofstad AP, Brueckmann M, Kaspers S, George JT, Zwiener I, Zinman B, Wanner C, Marx N, Mancia G, Anker SD, Mahfoud F. Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME. J Hypertens. 2020 Sep;38(9):1829-1840. doi: 10.1097/HJH.0000000000002492.
- Inzucchi SE, Khunti K, Fitchett DH, Wanner C, Mattheus M, George JT, Ofstad AP, Zinman B. Cardiovascular Benefit of Empagliflozin Across the Spectrum of Cardiovascular Risk Factor Control in the EMPA-REG OUTCOME Trial. J Clin Endocrinol Metab. 2020 Sep 1;105(9):3025-35. doi: 10.1210/clinem/dgaa321.
- Ferreira JP, Fitchett D, Ofstad AP, Kraus BJ, Wanner C, Zwiener I, Zinman B, Lauer S, George JT, Rossignol P, Zannad F. Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial. Am J Hypertens. 2020 Dec 31;33(12):1092-1101. doi: 10.1093/ajh/hpaa073.
- Perkovic V, Koitka-Weber A, Cooper ME, Schernthaner G, Pfarr E, Woerle HJ, von Eynatten M, Wanner C. Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME(R) trial. Nephrol Dial Transplant. 2020 Dec 4;35(12):2103-2111. doi: 10.1093/ndt/gfz179.
- Kansal A, Reifsnider OS, Proskorovsky I, Zheng Y, Pfarr E, George JT, Kandaswamy P, Ruffolo A. Cost-effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA-REG OUTCOME trial. Diabet Med. 2019 Nov;36(11):1494-1502. doi: 10.1111/dme.14076. Epub 2019 Jul 23.
- Butler J, Zannad F, Fitchett D, Zinman B, Koitka-Weber A, von Eynatten M, Zwiener I, George J, Brueckmann M, Cheung AK, Wanner C. Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure. Circ Heart Fail. 2019 Jun;12(6):e005875. doi: 10.1161/CIRCHEARTFAILURE.118.005875. Epub 2019 Jun 5.
- Verma S, Wanner C, Zwiener I, Ofstad AP, George JT, Fitchett D, Zinman B; EMPA-REG OUTCOME Investigators. Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes. J Am Coll Cardiol. 2019 Jun 4;73(21):2780-2782. doi: 10.1016/j.jacc.2019.03.002. Epub 2019 Mar 15. No abstract available.
- Januzzi J, Ferreira JP, Bohm M, Kaul S, Wanner C, Brueckmann M, Petrie MC, Ofstad AP, Zeller C, George J, Fitchett D, Zannad F. Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline. Eur J Heart Fail. 2019 Mar;21(3):386-388. doi: 10.1002/ejhf.1419. Epub 2019 Feb 14. No abstract available.
- Fitchett D, Inzucchi SE, Cannon CP, McGuire DK, Scirica BM, Johansen OE, Sambevski S, Kaspers S, Pfarr E, George JT, Zinman B. Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial. Circulation. 2019 Mar 12;139(11):1384-1395. doi: 10.1161/CIRCULATIONAHA.118.037778.
- Verma S, Mazer CD, Fitchett D, Inzucchi SE, Pfarr E, George JT, Zinman B. Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME(R) randomised trial. Diabetologia. 2018 Aug;61(8):1712-1723. doi: 10.1007/s00125-018-4644-9. Epub 2018 May 19.
- Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, Hantel S, Bluhmki E, Lachin JM. How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2018 Feb;41(2):356-363. doi: 10.2337/dc17-1096. Epub 2017 Dec 4.
- Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, Woerle HJ, Broedl UC, von Eynatten M, Zinman B; EMPA-REG OUTCOME Investigators. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease. Circulation. 2018 Jan 9;137(2):119-129. doi: 10.1161/CIRCULATIONAHA.117.028268. Epub 2017 Sep 13.
- Cherney DZI, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, von Eynatten M, Wanner C. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 Aug;5(8):610-621. doi: 10.1016/S2213-8587(17)30182-1. Epub 2017 Jun 27.
- Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, Mattheus M, Woerle HJ, Broedl UC, Johansen OE, Albers GW, Diener HC; EMPA-REG OUTCOME Investigators (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients). Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Stroke. 2017 May;48(5):1218-1225. doi: 10.1161/STROKEAHA.116.015756. Epub 2017 Apr 6.
- Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920. Epub 2016 Jun 14.
- Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
- Zinman B, Inzucchi SE, Lachin JM, Wanner C, Ferrari R, Fitchett D, Bluhmki E, Hantel S, Kempthorne-Rawson J, Newman J, Johansen OE, Woerle HJ, Broedl UC. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME). Cardiovasc Diabetol. 2014 Jun 19;13:102. doi: 10.1186/1475-2840-13-102.
有用的网址
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2010年7月1日
初级完成 (实际的)
2015年4月1日
研究完成 (实际的)
2015年4月1日
研究注册日期
首次提交
2010年5月26日
首先提交符合 QC 标准的
2010年5月26日
首次发布 (估计)
2010年5月27日
研究记录更新
最后更新发布 (估计)
2016年5月16日
上次提交的符合 QC 标准的更新
2016年4月7日
最后验证
2016年4月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.